Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. (2014)

First Author: Reilly JT
Attributed to:  Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.12985

PubMed Identifier: 24961987

Publication URI: http://europepmc.org/abstract/MED/24961987

Type: Journal Article/Review

Volume: 167

Parent Publication: British journal of haematology

Issue: 3

ISSN: 0007-1048